OTC · Basic materials

Kraig Biocraft Laboratories, Inc. (KBLB)

It posted a net loss of $4.1M. In fiscal 2025 capital spending exceeded operating cash flow by $1.8M. At June 30, 2026 it held $3.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch KBLB in 60 seconds

Price

$0.07

-1.43% on the day · September 28, 2026

52-week range $0.07 to $0.16

Market cap

$75.9M

What Kraig Biocraft Laboratories, Inc. does

Kraig Biocraft Laboratories, Inc. is registered with the SEC under industry code SIC 2820 (Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)). Its shares trade on OTC under the ticker KBLB.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$3.4M	-$3.6M	$0.00	-$1.8M
2024	n/a	-$3.1M	-$3.4M	$0.00	-$1.8M
2023	n/a	-$2.6M	-$3M	$0.00	-$1.3M
2022	n/a	-$2.1M	-$3.8M	$0.00	-$1.9M
2021	n/a	-$2.8M	-$8M	-$0.01	-$1.9M
2020	n/a	-$4.5M	-$5M	-$0.01	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Kraig Biocraft Laboratories, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 13, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.00 versus $0.00.
May 22, 2026
Securities offering prospectus 424B3
May 22, 2026
Securities offering prospectus 424B3
May 22, 2026
Securities offering prospectus 424B3
May 14, 2026
Quarterly report 10-Q · period to March 31, 2026Diluted EPS $0.00 versus $0.00.
May 14, 2026
Securities offering prospectus 424B3
May 14, 2026
Securities offering prospectus 424B3
May 11, 2026
Form POS AM filing POS AM
April 30, 2026
Securities offering prospectus 424B3
April 21, 2026
Form POS AM filing POS AM

Recent insider filings (Forms 3, 4 and 144): 10, the latest on May 29, 2025. Insider transactions on SEC

All filings on SEC EDGAR

Questions about KBLB

What does Kraig Biocraft Laboratories, Inc. do?

Kraig Biocraft Laboratories, Inc. is registered with the SEC under industry code SIC 2820 (Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)). Its shares trade on OTC under the ticker KBLB.

Is Kraig Biocraft Laboratories, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $4.1M.

When did Kraig Biocraft Laboratories, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.

Similar companies

Sibanye Stillwater Ltd

SPTJF

Sinopec Shanghai Petrochemical Co Ltd

Compare KBLB with

Compare KBLB with any company

Follow KBLB

Get an email when Kraig Biocraft Laboratories, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow KBLB: get an email when it files

Where the numbers come from

Financial figures are the values Kraig Biocraft Laboratories, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.